BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27558881)

  • 21. F-18 FDG PET-CT findings in Mikulicz disease and systemic involvement of IgG4-related lesions.
    Suga K; Kawakami Y; Hiyama A; Hori K; Takeuchi M
    Clin Nucl Med; 2009 Mar; 34(3):164-7. PubMed ID: 19352281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunobiology and clinical characteristics of IgG4 related diseases.
    Takahashi H; Yamamoto M; Tabeya T; Suzuki C; Naishiro Y; Shinomura Y; Imai K
    J Autoimmun; 2012 Aug; 39(1-2):93-6. PubMed ID: 22341851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach.
    Bledsoe JR; Della-Torre E; Rovati L; Deshpande V
    APMIS; 2018 Jun; 126(6):459-476. PubMed ID: 29924455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's disease.
    Abud-Mendoza C
    Reumatol Clin; 2013; 9(3):133-5. PubMed ID: 23570964
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical characteristics of patients with IgG4-related disease with infiltration of the labial salivary gland by IgG4-positive cells.
    Abe A; Takano K; Seki N; Jitsukawa S; Yamamoto M; Takahashi H; Himi T
    Mod Rheumatol; 2014 Nov; 24(6):949-52. PubMed ID: 24670136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of complement as a biomarker of disease activity in 4 cases of IgG4-related disease with retroperitoneal fibrosis.
    Kihara M; Sugihara T; Hosoya T; Miyasaka N
    Clin Exp Rheumatol; 2013; 31(6):947-9. PubMed ID: 24021494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights.
    Masaki Y; Sugai S; Umehara H
    J Rheumatol; 2010 Jul; 37(7):1380-5. PubMed ID: 20436071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory involvement in IgG4-related Mikulicz's disease.
    Matsui S; Taki H; Shinoda K; Suzuki K; Hayashi R; Tobe K; Tokimitsu Y; Ishida M; Fushiki H; Seto H; Fukuoka J; Ishizawa S
    Mod Rheumatol; 2012 Feb; 22(1):31-9. PubMed ID: 21811890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis.
    Detlefsen S; Klöppel G
    Virchows Arch; 2018 Apr; 472(4):545-556. PubMed ID: 29196804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of a new disease concept, IgG4-related thyroiditis: comments on the article by Watanabe et al.
    Nagashima T; Fukushima N; Minota S
    Scand J Rheumatol; 2013; 42(6):510-1. PubMed ID: 24256486
    [No Abstract]   [Full Text] [Related]  

  • 31. The protean manifestations of IgG4-RD in gastrointestinal disorders.
    Sarkar A; Pitchumoni CS
    Dis Mon; 2015 Dec; 61(12):493-515. PubMed ID: 26608265
    [No Abstract]   [Full Text] [Related]  

  • 32. IgG4-related ocular adnexal disease mimicking thyroid-associated orbitopathy.
    Inaba H; Hayakawa T; Miyamoto W; Takeshima K; Yamaoka H; Furukawa Y; Kawashima H; Ariyasu H; Wakasaki H; Furuta H; Nishi M; Nakao T; Sasaki H; Okada Y; Matsunaga K; Nakamura Y; Akamizu T
    Intern Med; 2013; 52(22):2545-51. PubMed ID: 24240795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cutting-edge of medicine; clinical features and diagnosis of IgG4-related disease (IgG4-RD)].
    Umehara H; Okazaki K; Chiba T
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2973-81. PubMed ID: 23214110
    [No Abstract]   [Full Text] [Related]  

  • 34. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity.
    Takahashi H; Yamamoto M; Suzuki C; Naishiro Y; Shinomura Y; Imai K
    Autoimmun Rev; 2010 Jul; 9(9):591-4. PubMed ID: 20457280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease.
    Culver EL; Sadler R; Bateman AC; Makuch M; Cargill T; Ferry B; Aalberse R; Barnes E; Rispens T
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1444-1452.e6. PubMed ID: 28223204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
    Umehara H; Okazaki K; Masaki Y; Kawano M; Yamamoto M; Saeki T; Matsui S; Sumida T; Mimori T; Tanaka Y; Tsubota K; Yoshino T; Kawa S; Suzuki R; Takegami T; Tomosugi N; Kurose N; Ishigaki Y; Azumi A; Kojima M; Nakamura S; Inoue D;
    Mod Rheumatol; 2012 Feb; 22(1):1-14. PubMed ID: 21881964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IgG4-related systemic disease/systemic IgG4-related disease].
    Yamamoto M; Takahashi H; Shinomura Y
    Rinsho Byori; 2010 May; 58(5):454-65. PubMed ID: 20560455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG4-related Disease - A Patient with Multiple Organ Involvement.
    Průcha M; Sedláčková L
    Prague Med Rep; 2017; 118(2-3):95-99. PubMed ID: 28922106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
    Yu WK; Kao SC; Yang CF; Lee FL; Tsai CC
    Jpn J Ophthalmol; 2015 Jan; 59(1):8-13. PubMed ID: 25373451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.